Assignee
QLSF BIOTHERAPEUTICS INC
US·4 granted patents·3 pending applications·2 citations·filing 2020–2025
Top patents by PatentIndex Score
7 records- 0178US11124572B2Humanized anti-PD-L1 antibodiesQLSF BIOTHERAPEUTICS INC·Filed 2020·Granted Sep 21, 2021·1 cites·18 claims
- 0276US12227582B2CD137 agonist antibodies and uses thereofQLSF BIOTHERAPEUTICS INC·Filed 2020·Granted Feb 18, 2025·1 cites·17 claims
- 0365US11643466B2Humanized anti-PD-L1 antibodiesQLSF BIOTHERAPEUTICS INC·Filed 2021·Granted May 9, 2023·0 cites·18 claims
- 0453US2025145727A1Cd137 agonist antibodies and uses thereofQLSF BIOTHERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0552US10858442B2Antibodies that target human CD47QLSF BIOTHERAPEUTICS INC·Filed 2020·Granted Dec 8, 2020·0 cites·23 claims
- 0649US2024084014A1Multispecific binding compounds that bind to pd-l1QLSF BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0746US2023374130A1Bispecific anti lrrc15 and cd3epsilon antibodiesQLSF BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →